My Cart

No products in the cart.

/
/
Voglibose & Repaglinide Tablets IP – VOGLIUS RAPID Tablets

Voglibose & Repaglinide Tablets IP – VOGLIUS RAPID Tablets

1,999.00

Voglibose 0.3 mg + Repaglinide 1mg
Packing – 10*10 ALU

Category:

Voglibose & Repaglinide Tablets IP: Enhance glycemic control with improved PP glucose management.

VOGLIUS RAPID Tablets: The Dual composition of Voglibose 0.3 mg + Repaglinide 1mg, Voglibose – help to slows down the glucose/carbohydrate absorption & digestion by inhibiting the alpha glycosidase enzyme that is responsible for breakdown of carbohydrates into glucose and cause postprandial hyperglycemia and Repaglinide, a meglinide derivative helps to stimulating the pancreatic secretion binds to ATP sensitive potassium channels on the pancreatic beta cells leading to insulin release which help to lower blood glucose levels.

Recommended By Specialists:
✅Endocrinologists: It is preferred to treat the disease associated with specialists for diabetes management.
✅General Physicians: It is preferred to treat the disease associated with routine diabetes care in adults.

Key benefits of Voglibose & Repaglinide Tablets IP – VOGLIUS RAPID Tablets:
Repaglinide has a rapid onset of action, suitable for patients experiencing spikes in blood sugar after meals (postprandial hypoglycaemia).
The synergistic effect of both anti-diabetic agents provides complementary action of both drugs with different mechanisms to manage T2DM.
Dual action against postprandial hyperglycemia as Voglibose delays the carbohydrate absorption while Repaglinide works by enhancing insulin secretion.

INDICATIONS:
Type 2 diabetes mellitus
Postprandial Hyperglycemia

Follow us on

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate

10% off when you sign up

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate

×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?